QPHARMA
The computed 12-month bankruptcy probability of QPHARMA is 1.1% (low). The 2023 annual accounts show equity of €61k and a net result of €59k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €61k |
| Net result | €59k |
| Active | 3 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2023 |
|---|---|
| Revenue | - |
| EBITDA | €81k |
| Net profit | €59k |
| Cash flow | €65k |
| Staff costs | - |
| Income taxes | €16k |
| Dividends | - |
| Total assets | €120k |
| Equity | €61k |
| Debt | €59k |
| of which ≤ 1y | €59k |
| of which > 1y | - |
| Working capital | €24k |
| Employees (FTE) | - |
| 2023 | |
|---|---|
| Current ratio | 1.41 |
| Quick ratio | 1.41 |
| Working capital ratio | 20.3% |
| Solvency | 50.9% |
| Debt / equity | 0.96 |
| Long-term debt ratio | - |
| Interest coverage | 1943.19 |
| Gross margin | - |
| Net margin | - |
| ROA | 48.8% |
| ROE | 95.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €120k |
| Fixed assets | 21/28 | €37k |
| Tangible fixed assets | 22/27 | €37k |
| Current assets | 29/58 | €84k |
| Amounts receivable within one year | 40/41 | €32k |
| Cash & bank | 54/58 | €50k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €120k |
| Equity | 10/15 | €61k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €59k |
| Amounts payable | 17/49 | €59k |
| Amounts payable within one year | 42/48 | €59k |
| Trade debts payable within one year | 44 | €184 |
| Income statement | ||
| Gross operating margin | 9900 | €81k |
| Operating result | 9901 | €75k |
| Financial charges | 65 | €42 |
| Result before taxes | 9903 | €75k |
| Income taxes | 67/77 | €16k |
| Net result for the period | 9904 | €59k |
| Result to be appropriated | 9905 | €59k |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 21-03-2023 |
| Status | Active |
| Postal code | 1180 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21616A0183/00Y048 | Brussels | 265 m² | 1 · 145 m² | 19.0 m · 5 fl. |
| 21673D0117/00M014 | Brussels | 217 m² | 1 · 93 m² | 16.1 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
02-04-2026 Act object · Seat change · Power of attorney
- Act object: Transfert du siège social -PU 02/01/26 · QPHARMA
- Seat change: new: Rue Xavier de Bue n° 27 bte 9 à 1180 Uccle, old: Avenue Brugmann 383 bte 2 à 1180 Uccle, effective_date: 2026-01-02 · QPHARMA
- Power of attorney: mandate: procéder aux différentes formalités liées à ces décisions auprès du Greffe du Tribunal de l'Entreprise · MBM Groupe sc srl
- Filing: date: 2026-03-26, location: greffe du tribunal de l'entreprise francophone de Bruxelles · QPHARMA
- Publication: date: 2026-04-02, publication: Belgisch Staatsblad - 02/04/2026 · QPHARMA
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Transfert du si\u00E8ge social -PU 02/01/26",
"value": "Transfert du si\u00E8ge social -PU 02/01/26",
"object": null,
"subject": "e1"
},
{
"type": "seat_change",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire d\u00E9cide de transf\u00E9rer le si\u00E8ge social de la soci\u00E9t\u00E9, \u00E0 partir de ce jour, \u00E0 l\u0027adresse suivante: Rue Xavier de Bue n\u00B0 27 bte 9 \u00E0 1180 Uccle",
"value": {
"new": "Rue Xavier de Bue n\u00B0 27 bte 9 \u00E0 1180 Uccle",
"old": "Avenue Brugmann 383 bte 2 \u00E0 1180 Uccle",
"effective_date": "2026-01-02"
},
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e mandate la soci\u00E9t\u00E9 MBM Groupe sc srl, dont les bureaux sont \u00E9tablis Avenue Tedesco 26 \u00E0 1160 Auderghem, BCE n\u00B00542.637.202 \u0433epr\u00E9sent\u00E9e par Mr Thierry Graulich et/ou Mr Christophe Dereume et /ou Mme Isabelle De Roose, aux fins de proc\u00E9der aux diff\u00E9rentes formalit\u00E9s li\u00E9es \u00E0 ces d\u00E9cisions aupr\u00E8s du Greffe du Tribunal de l\u0027Entreprise.",
"value": {
"mandate": "proc\u00E9der aux diff\u00E9rentes formalit\u00E9s li\u00E9es \u00E0 ces d\u00E9cisions aupr\u00E8s du Greffe du Tribunal de l\u0027Entreprise",
"representatives": [
"Thierry Graulich",
"Christophe Dereume",
"Isabelle De Roose"
]
},
"object": "e1",
"subject": "e2"
},
{
"type": "filing",
"quote": "Re\u00E7u le *26045563* 2 6 MARS 2026 au greffe du tribunal de l\u0027entreprise francophone de Bruxeles",
"value": {
"date": "2026-03-26",
"location": "greffe du tribunal de l\u0027entreprise francophone de Bruxelles"
},
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 02/04/2026 - Annexes du Moniteur belge",
"value": {
"date": "2026-04-02",
"publication": "Belgisch Staatsblad - 02/04/2026"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1357,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0799.745.895",
"kind": "company",
"name": "QPHARMA",
"attrs": {
"new_seat": "Rue Xavier de Bue n\u00B0 27 bte 9 \u00E0 1180 Uccle",
"old_seat": "Avenue Brugmann 383 bte 2 \u00E0 1180 Uccle",
"legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e2",
"kbo": "0542.637.202",
"kind": "company",
"name": "MBM Groupe sc srl",
"attrs": {
"address": "Avenue Tedesco 26 \u00E0 1160 Auderghem"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Thierry Graulich",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Christophe Dereume",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Isabelle De Roose",
"attrs": {}
}
]
}05-04-2024 Registered office moved from Woluwe-Saint-Lambert to Uccle
- Avenue du Roi Chevalier 13, 1200 Woluwe-Saint-Lambert → Avenue Brugmann 383, 1180 Uccle
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Uccle",
"region": "Brussels Gewest",
"street": "Avenue Brugmann",
"country": "BE",
"postcode": "1180",
"box_number": "2",
"street_number": "383"
},
"old_address": {
"city": "Woluwe-Saint-Lambert",
"region": "Brussels Gewest",
"street": "Avenue du Roi Chevalier",
"country": "BE",
"postcode": "1200",
"box_number": null,
"street_number": "13"
},
"effective_date": "2023-12-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire, tenue au sl\u00E8ge social de la soci\u00E9t\u00E9 le 1er d\u00E9cembre 2023, d\u00E9cide de transf\u00E9rer le si\u00E8ge social de la soci\u00E9t\u00E9, \u00E0 partir de ce jour, \u00E0 l\u0027adresse suivante: Avenue Brugmann 383, boite 2, 1180 Uccle"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0799.745.895",
"name_full": "QPHARMA",
"legal_form": "SRL"
}
}23-03-2023 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1200 Woluwe-Saint-Lambert, Avenue du Roi Chevalier 13",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1997-01-13",
"name": "Simon No\u00EBl Yvon QUIN",
"niss": null,
"address": "7387 Honnelles, rue Longue, 26"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "Simon No\u00EBl Yvon QUIN",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "0799.745.895",
"name_full": "QPHARMA",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2023-03-20",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | QPHARMA |